Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -75,749 | -48,279 | -65,744 | -43,759 | -19,515 |
| Depreciation Amortization | 5,582 | 4,296 | 4,408 | 3,331 | 1,004 |
| Accounts receivable | -9,767 | -2,078 | 2,488 | -2,862 | -94 |
| Accounts payable and accrued liabilities | 1,899 | 3,274 | -21 | 2,812 | 477 |
| Other Working Capital | -33,781 | -33,503 | -3,688 | -282 | -1,008 |
| Other Operating Activity | 9,813 | 96 | -122 | 3,488 | 867 |
| Operating Cash Flow | $-102,003 | $-76,194 | $-62,679 | $-37,272 | $-18,269 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 5,390 | 16,658 |
| PPE Investments | -12,725 | -3,812 | -2,096 | -2,676 | -73 |
| Net Acquisitions | N/A | N/A | N/A | 12,500 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -15,680 |
| Investing Cash Flow | $-12,725 | $-3,812 | $-2,096 | $15,214 | $905 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 27,500 | 72,500 | N/A | 45,000 | 4,000 |
| Debt Repayment | -14,812 | -39,290 | -36 | -21,807 | -15 |
| Common Stock Issued | 131,209 | 48,472 | 42,958 | 39,207 | 12,901 |
| Other Financing Activity | 0 | -1,680 | 0 | -1,650 | -47 |
| Financing Cash Flow | $143,897 | $80,003 | $42,922 | $60,751 | $16,838 |
| Beginning Cash Position | 26,752 | 26,755 | 48,608 | 9,915 | 10,441 |
| End Cash Position | 55,921 | 26,752 | 26,755 | 48,608 | 9,915 |
| Net Cash Flow | $29,169 | $-3 | $-21,853 | $38,693 | $-526 |
| Free Cash Flow | |||||
| Operating Cash Flow | -102,003 | -76,194 | -62,679 | -37,272 | -18,269 |
| Capital Expenditure | -12,727 | -3,812 | -2,096 | -2,676 | -73 |
| Free Cash Flow | -114,730 | -80,005 | -64,774 | -39,948 | -18,342 |